Oncology was the therapeutic area with the largest potential in M&A value of protfolio optimization, as of early 2020. The potential deal multiplier stood at six, with a potential asset value of 84 billion U.S. dollars. This statistic illustrates the life sciences M&A value of portfolio optimization worldwide as of 2020, by five selected therapeutic areas.
Life sciences M&A value of portfolio optimization worldwide as of 2020, by select therapeutic area
Characteristic
Aggregate revenues of sub-scale assets (in bn USD)
Potential asset value (in bn USD)
Potential deal multiple
Oncology
14
84
6
Immunology
3
15
5
Central nervous system disorders
23
115
5
Cardiovascular/metabolic disease
11
44
4
Infectious disease
9
27
3
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
EY. (January 12, 2020). Life sciences M&A value of portfolio optimization worldwide as of 2020, by select therapeutic area [Graph]. In Statista. Retrieved December 25, 2024, from https://www.statista.com/statistics/1091724/global-life-sciences-manda-value-of-portfolio-optimization-by-therapeutic-area/
EY. "Life sciences M&A value of portfolio optimization worldwide as of 2020, by select therapeutic area." Chart. January 12, 2020. Statista. Accessed December 25, 2024. https://www.statista.com/statistics/1091724/global-life-sciences-manda-value-of-portfolio-optimization-by-therapeutic-area/
EY. (2020). Life sciences M&A value of portfolio optimization worldwide as of 2020, by select therapeutic area. Statista. Statista Inc.. Accessed: December 25, 2024. https://www.statista.com/statistics/1091724/global-life-sciences-manda-value-of-portfolio-optimization-by-therapeutic-area/
EY. "Life Sciences M&a Value of Portfolio Optimization Worldwide as of 2020, by Select Therapeutic Area." Statista, Statista Inc., 12 Jan 2020, https://www.statista.com/statistics/1091724/global-life-sciences-manda-value-of-portfolio-optimization-by-therapeutic-area/
EY, Life sciences M&A value of portfolio optimization worldwide as of 2020, by select therapeutic area Statista, https://www.statista.com/statistics/1091724/global-life-sciences-manda-value-of-portfolio-optimization-by-therapeutic-area/ (last visited December 25, 2024)
Life sciences M&A value of portfolio optimization worldwide as of 2020, by select therapeutic area [Graph], EY, January 12, 2020. [Online]. Available: https://www.statista.com/statistics/1091724/global-life-sciences-manda-value-of-portfolio-optimization-by-therapeutic-area/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.